Sedative-Hypnotic Drugs Market Forecast Report | Analysis, Insights, Size And Opportunities 2024 - 2033

"The new report published by The Business Research Company, titled Sedative-Hypnotic Drugs Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the sedative-hypnotic drugs market size has grown strongly in recent years. It will grow from $3.29 billion in 2023 to $3.57 billion in 2024 at a compound annual growth rate (CAGR) of 8.6%. The sedative-hypnotic drugs market size is expected to see strong growth in the next few years. It will grow to $5.00 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15666&type=smp

Stress Surge Predicted To Fuel Growth In The Sedative-Hypnotic Drugs Market
The increased stress levels are expected to propel the growth of the sedative-hypnotic drugs market going forward. Stress levels refer to the mental or emotional exhaustion individuals experience as a result of unavoidable or challenging circumstances. Several driving factors for stress levels include struggling to balance work responsibilities with personal life, inadequate coping mechanisms, and increasing work pressure among employees. Sedative-hypnotic drugs serve as pharmacological agents primarily intended to induce a state of calmness, diminish anxiety levels, and alleviate tension within individuals, often through their tranquilizing effects on the central nervous system. For instance, in December 2022, according to a survey of 2,212 American adults conducted by the American Psychiatric Association, a US-based national medical specialty organization, over 26% (more than one in four) of respondents indicated they expected to encounter increased stress at the beginning of 2023, marking a rise from the 20% reported in the previous year. Therefore, the increased stress levels are driving the growth of the sedative-hypnotic drugs market.

Sedative-Hypnotic Drug Players Embrace Agitation Treatment Films For Competitive Advantage
Major companies operating in the sedative-hypnotic drugs market are focusing on expanding their product portfolio by adding products, such as innovative sublingual film, for acute treatment of agitation and to gain a competitive edge in the market. A sublingual film for the acute treatment of agitation refers to a thin, dissolvable film containing medication that is placed under the tongue for rapid absorption into the bloodstream. For instance, in April 2022, BioXcel Therapeutics Inc., a US-based biopharmaceutical company, announced the launch of IGALMI. It is a sublingual film designed for the acute management of agitation linked to schizophrenia or bipolar I or II disorder in adults. It is the first new acute treatment for schizophrenia or bipolar disorder-associated agitation in nearly a decade and represents a differentiated approach to helping patients manage this difficult and debilitating symptom. The approval of IGALMI marks a significant milestone, offering healthcare teams an innovative tool for managing agitation with its rapid onset of action and self-administered film format.

The sedative-hypnotic drugs market covered in this report is segmented -

1) By Drug Class: Benzodiazepines, Barbiturates, Antihistamines, Nonbenzodiazepine, Other Drug Classes
2) By Route of Administration: Oral, Parenteral, Other Routes of Administration
3) By Disease Type: Sleep Disorders, Anesthesia, Pain, Other Disease Types
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channels
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @ https://www.thebusinessresearchcompany.com/Discount?id=15666&type=discount

Major companies operating in the sedative-hypnotic drugs market are Sun Pharmaceutical Industries Inc., Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis AG, AstraZeneca Plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Mylan N.V., Fresenius Kabi AG, Eli Lilly and Co., Aurobindo Pharma Limited, Cipla Inc., Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Pharmaceuticals Inc., Allergan Pharmaceuticals Inc., Glenmark Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd.

Contents of the report:
1. Executive Summary
2. Sedative-Hypnotic Drugs Market Report Structure
3. Sedative-Hypnotic Drugs Market Trends And Strategies
4. Sedative-Hypnotic Drugs Market - Macro Economic Scenario
5. Sedative-Hypnotic Drugs Market Size And Growth
…..
27. Sedative-Hypnotic Drugs Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/sedative-hypnotic-drugs-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

"Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide."

This release was published on openPR.